Mapping the neural tapestry:Perinatal depressive symptoms, antidepressant use, and child brain development
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
The developing brain is shaped by a complex interplay of early environmental exposures and biological susceptibility. This thesis investigated how perinatal maternal depressive symptoms, prenatal antidepressant exposure, and neurotransmitter-related genetic liability are associated with structural and functional brain development from childhood into adolescence. Drawing primarily on large population-based cohort studies with longitudinal neuroimaging data, this work addressed central questions in psychiatric epidemiology regarding the timing, specificity, developmental course, and potential mechanisms of early-life influences on neurodevelopment. A particular focus was placed on disentangling the associations of maternal depressive symptoms from those of selective serotonin reuptake inhibitor (SSRI) use during pregnancy, while also extending beyond exposure-based models to examine neurotransmitter-informed pathways of vulnerability. The first part of the thesis examined whether perinatal depressive symptoms and prenatal SSRI exposure are associated with offspring brain morphology, white matter microstructure, and functional connectivity. The findings indicate that prenatal SSRI exposure is associated with subtle differences in offspring brain development, including alterations in global and regional brain morphology, particularly in corticolimbic regions implicated in emotional regulation. Some of these differences appeared to attenuate over time, suggesting developmental plasticity. Maternal depressive symptoms were likewise associated with offspring neurodevelopment, although the observed patterns were generally more circumscribed and differed across structural and functional domains. Collectively, these findings underscore the importance of longitudinal designs and careful consideration of confounding by indication when evaluating prenatal psychopharmacological exposure in observational research. The second part of the thesis focused on neurobiological mechanisms that may underlie individual differences in adolescent brain morphology and mental health. Using pathway-specific polygenic risk scores, this work examined whether genetic liability for psychiatric disorders within serotonergic, dopaminergic, glutamatergic, and GABAergic systems is associated with cortical brain morphology in adolescence. In addition, serotonin-informed neuroanatomical mapping was used to investigate whether structural variation in serotonin-related brain regions is associated with behavioral and emotional problems. Together, the findings support a developmental framework in which perinatal exposures and neurotransmitter-related biological susceptibility jointly contribute to the architecture of the developing brain. This thesis advances understanding of the pathways linking perinatal mental health, antidepressant exposure, and molecular neurobiology to child and adolescent neurodevelopment.
Fields of Study & Subjects
Maternal Mental Health During Pregnancy and Postpartum
Prenatal Substance Exposure Effects
Fetal and Pediatric Neurological Disorders
Publication details
- Journal / source
- EUR Research Repository (Erasmus University Rotterdam)
- Publication date
- 20 May 2026
- Language
- EN
- Document type
- Thesis